The revenue beat and raised guidance confirm strong commercial momentum, especially in Shield screening. The GAAP EPS miss is secondary given the non-cash stock-based compensation. Watch for Shield volume trajectory toward 285K-290K tests and further margin expansion from the new lower-COGS workflow.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 6 $150.87entry
- T+1 · 8d ago +5.25%α +2.88% · $158.79
- T+5 · 4d ago +0.55%α −2.04% · $151.70
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Guardant Health reported Q3 2026 revenue of $361.0M, up 36% YoY and above the $350.6M consensus, while GAAP net loss per share was -$0.93, wider than the -$0.31 consensus estimate. The company raised full-year 2026 revenue guidance to $1.36-$1.37B (from $1.34-$1.36B), driven by strong Screening (Shield) and Oncology volume growth. The EPS miss reflects elevated operating expenses and stock-based compensation, but the revenue beat and guidance raise support the bullish case.
Key Financial Metrics
Key Facts
- Q3 2026 total revenue $361.0M, +36% YoY from $265.2M
- GAAP net loss per share -$0.93 vs consensus -$0.31
- Non-GAAP net loss per share -$0.29 vs -$0.39 YoY
- Oncology revenue $231.3M (+25% YoY), 117,000 tests (+58%)
- Screening revenue $67.6M (+180% YoY), 83,000 Shield tests (+246%)
- Biopharma Data revenue $59.0M (+8% YoY)
- Non-GAAP gross margin 67%, up from 66% YoY
- Full-year 2026 revenue guidance raised to $1.36-$1.37B (38%-40% growth)
- Screening revenue guidance raised to $233-$238M, Shield volume 285K-290K tests
- Free cash flow burn -$37.2M, improved from -$45.8M YoY
- Cash and equivalents $1.1B as of Sep 30, 2026
Financial Impact
Revenue beat consensus by $10.4M (+3.0%); EPS missed by $0.62; guidance raised by $20M at midpoint
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Oncology | $231.3M | +25.4% |
| Biopharma and data | $59.0M | +7.7% |
| Screening | $67.6M | +180.4% |
| Licensing and other | $3.1M | +60.2% |
Risk Factors
- GAAP net loss widened to -$124.4M from -$92.7M YoY due to rising operating expenses
- Full-year free cash flow burn guidance widened to $205M-$220M from $195M-$205M
- Non-GAAP operating expenses raised to $1.105-$1.125B, indicating continued investment spend
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001576280-26-000043 |
| Document: gh-20261105.htm | 0001576280-26-000043 |
| Document: 0001576280-26-000043-index-headers.html | 0001576280-26-000043 |
| Document: 0001576280-26-000043-index.html | 0001576280-26-000043 |
| Document: 0001576280-26-000043.txt | 0001576280-26-000043 |
| 8-K Data (Synthetic) | 0001576280-26-000043 |
Track record
38 reports on GH
3 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +22.49% at T+60 after the May 27, 2026 report. 3 of 6 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $145.04 Now $144.03 −0.70% settles Dec 16
- Nov 12, 20264d ago 3 Neutral 1/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
- Nov 5, 202611d ago 8-K Bullish 6/10 Viewing Entry $150.87 Now $144.03 −4.53% settles Dec 7
- Nov 5, 202611d ago SC 13G Neutral 3/10 Entry $153.43 Now $144.03 −6.13% settles Dec 4
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $168.58 Now $144.03 −14.56% settles Dec 3
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $175.00 Now $144.03 −17.70% settles Dec 2
- Oct 21, 202626d ago Institutional Cluster Neutral 3/10 Entry $162.94 Now $144.03 −11.61% settles Nov 19
- Oct 14, 20264w ago 144 Neutral 2/10 Entry $165.88 to $154.86 Now $144.03 −13.17% ▼ −6.64% −4.74% vs SPY
- Sep 17, 20268w ago Insider Cluster Bearish 5/10 Entry $179.38 to $158.60 Now $144.03 +19.71% ▲ +11.58% +11.79% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers